60 Degrees Pharmaceuticals, Inc. (SXTP)

NASDAQ: SXTP · IEX Real-Time Price · USD

0.241

-0.005 (-2.19%)

At close: Apr 19, 2024, 4:00 PM

0.253

+0.012 (4.98%)

After-hours: Apr 19, 2024, 7:42 PM EDT

SXTP Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020
Revenue	0.25	0.51	5.5	1.85
Revenue Growth (YoY)	-50.40%	-90.71%	197.98%	-
Cost of Revenue	0.47	0.43	5.19	0.37
Gross Profit	-0.22	0.08	0.31	1.48
Selling, General & Admin	4.24	1.3	1.12	1.46
Research & Development	0.69	0.53	5.51	0.81
Operating Expenses	4.93	1.83	6.63	2.26
Operating Income	-5.15	-1.75	-6.32	-0.79
Interest Expense / Income	2.29	3.99	3.17	2.63
Other Expense / Income	-3.68	0.44	-5.24	-0.38
Pretax Income	-3.77	-6.18	-4.25	-3.03
Income Tax	0	0	0	0
Net Income	-3.77	-6.18	-4.25	-3.03
Preferred Dividends	0.22	0	0	0
Net Income Common	-3.92	-6.18	-4.25	-3.03
Shares Outstanding (Basic)	4	2	2	-
Shares Outstanding (Diluted)	4	2	-	-
Shares Change	67.26%	-0.77%	-	-
EPS (Basic)	-0.99	-2.61	-	-
EPS (Diluted)	-0.99	-2.61	-	-
Free Cash Flow	-4.64	-1.04	-0.68	-0.24
Free Cash Flow Per Share	-1.17	-0.44	-0.29	-
Gross Margin	-87.15%	15.42%	5.63%	80.06%
Operating Margin	-2032.78%	-342.41%	-114.80%	-42.58%
Profit Margin	-1547.71%	-1209.65%	-77.27%	-164.30%
Free Cash Flow Margin	-1830.05%	-204.03%	-12.44%	-12.90%
EBITDA	-1.38	-2.11	-1.01	-0.38
EBITDA Margin	-543.61%	-413.35%	-18.29%	-20.34%
Depreciation & Amortization	0.1	0.08	0.07	0.03
EBIT	-1.48	-2.19	-1.08	-0.4
EBIT Margin	-583.19%	-428.76%	-19.59%	-21.85%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).